Monoclonal Antibody (mAb) 216 With Chemotherapy in Adult Relapsed or Refractory B-Lineage Acute Lymphoblastic Leukemia
Clinical trial NCT00313079 · COMPLETED
Trial details
- NCT number
- NCT00313079
- Sponsor
- Steven E. Coutre
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2006-05-01
- Primary completion
- 2009-02-01
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.